The University of Chicago Header Logo

Connection

Susan L. Cohn to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Susan L. Cohn has written about Antibodies, Monoclonal, Humanized.
Susan L. Cohn
Connection Strength
0.121
Antibodies, Monoclonal, Humanized
  1. Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial. Lancet Oncol. 2020 01; 21(1):121-133.
    View in: PubMed
    Score: 0.121
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.